Expedited Review for New Animal Drug Applications for Human Pathogen Reduction Claims; Withdrawal of Guidance
Health and Human Services Department; Food and Drug Administration · 2011
Read Expedited Review for New Animal Drug Applications for Human Pathogen Reduction Claims; Withdrawal of Guidance by Health and Human Services Department; Food and Drug Administration (2011) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/uslaw-fr-2011-12624.txt.
Description
Notice published in the Federal Register on 2011-05-24 by Health and Human Services Department; Food and Drug Administration. Text from federalregister.gov (official edition: govinfo). [FR Doc No: 2011-12624] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2001-D-0066] (Formerly Docket No. 2001D-0107) Expedited Review for New Animal Drug Applications for Human Pathogen Reduction Claims; Withdrawal of Guidance AGENCY: Food and Drug Administration, HHS. ACTION: Notice; withdrawal. ----------------------------------------------------------------------- SUMMARY:.
Catalog record
| CREATOR | Health and Human Services Department; Food and Drug Administration |
|---|---|
| YEAR | 2011 |
| COLLECTION | LAW |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | Public Domain |
| RIGHTS | PUBLIC DOMAIN |
| SOURCE | Federal Register |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Expedited Review for New Animal Drug Applications for Human Pathogen Reduction Claims; Withdrawal of Guidance
Citation: us:fr:2011-12624
Creator: Health and Human Services Department; Food and Drug Administration
Year: 2011
Source-URL: https://www.federalregister.gov/documents/2011/05/24/2011-12624/expedited-review-for-new-animal-drug-applications-for-human-pathogen-reduction-claims-withdrawal-of
Context: Notice published in the Federal Register on 2011-05-24 by Health and Human Services Department; Food and Drug Administration. Text from federalregister.gov (official edition: govinfo).
[FR Doc No: 2011-12624]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2001-D-0066] (Formerly Docket No. 2001D-0107)
Expedited Review for New Animal Drug Applications for Human
Pathogen Reduction Claims; Withdrawal of Guidance
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; withdrawal.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
withdrawal of a guidance that was issued on March 9, 2001.
DATES: May 24, 2011.
FOR FURTHER INFORMATION CONTACT: Steven Vaughn, Center for Veterinary
Medicine (HFV-100), Food and Drug Administration, 7520 Standish Pl.,
Rockville, MD 20855, 240-276-8300.
SUPPLEMENTARY INFORMATION: In a notice published in the Federal
Register of March 9, 2001 (66 FR 14155), FDA announced the availability
of a guidance for industry 121 entitled ``Expedited Review for
New Animal Drug Applications for Human Pathogen Reduction Claims.''
The guidance predates the enactment of the Animal Drug User Fee Act
(ADUFA) of 2003, which was reauthorized by Congress in 2008. ADUFA
authorized FDA to collect fees for certain animal drug applications and
for the establishments, products, and sponsors associated with these
and previously approved animal drug applications, in support of the
review of animal drug products. As a result of these increased
resources, the efficiencies of our current administrative processes,
including the phased review and end review amendment processes, we have
significantly reduced our review timeframes and afford sponsors a more
efficient pathway to regulatory approval.
At the time the guidance was issued, FDA's review timeframes for
new animal drug applications were considerably longer. As noted
previously, significant changes have occurred in the Agency's processes
and timeframes for reviewing new animal drug applications and the
process for expedited review status contained in this guidance is
outdated and no longer needed to assure the efficient review of these
new animal drug applications.
Dated: May 4, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-12624 Filed 5-23-11; 8:45 am]